Rome Area, Italy
Executive Director, Clinical Trials Center, Policlinico Gemelli, Rome, Italy
Pharmaceuticals
Education
Università di Roma Tor Vergata 1983 — 1988
Specialist, Surgery
Università Cattolica del Sacro Cuore 1977 — 1983
M.D., Medicine
Liceo Classico T. Gargallo, Siracusa 1972 — 1977
High School Diploma, Classical Studies
Experience
Catholic University School of Medicine January 2013 - Present
Molipharma, a spin-off of the Catholic University School of Medicine January 2014 - Present
SigmaTau SpA January 2011 - December 2012
Sigma Tau SpA January 2007 - December 2010
Sigma Tau Research, Inc. January 2004 - December 2007
Sigma Tau Research, Inc. January 2001 - December 2003
Sigma-Tau Pharmaceuticals, Inc. January 1996 - December 2000
Sigma Tau SpA December 1991 - December 1995
Skills
Biotechnology, Medical Affairs, Regulatory Strategy, SOP, Drug Discovery, Neuropharmacology, Therapeutic Areas, Hematology, Pharmacology, ICH-GCP, CTMS, Infectious Diseases, Pharmaceutical Industry, Medical Writing, CRO, Sop, Medicine, Orphan diseases, Pharmaceutical Sales, Pharmacovigilance, Oncology, Immunology, Project Portfolio..., R&D, Rare Diseases, Management, Administrative Work, GCP, General Administration, Pharmaceutics, Cardiovascular Medicine, Regulatory Submissions, FDA, Market Access, Clinical Development, Diabetes, Metabolism, Clinical Trials, Lifesciences, Dermatology, Biopharmaceuticals, Cardiology, Strategy, Life Sciences, Product Development, Regulatory Affairs, Clinical Research, Drug Development, Metabolic Diseases, Medical Devices